InsiderClue
Insiders · Profile

HIGGINS JOHN L

Director at OmniAb · Director at Bio-Techne · Director at LIGAND PHARMACEUTICALS. Filing since 15 Jun 2007. CIK 0001208906

OABI OmniAb, Inc. Director · 8 trades TECH Bio-Techne Director · 10 trades LGND LIGAND PHARMACEUTICALS INC Director · 42 trades
Company
Date
Role
Action
Shares
Amount
Of holding
OABI OmniAb, Inc.
7 Nov 2025
Director
Bought
41,038
$56.63K
1.4%
OABI OmniAb, Inc.
6 Nov 2025
Director
Bought
36,223
$51.07K
1.3%
OABI OmniAb, Inc.
12 May 2025
Director
Bought
65,000
$93.60K
2.3%
OABI OmniAb, Inc.
21 Mar 2025
Director
Bought
4,000
$9.12K
0.1%
OABI OmniAb, Inc.
20 Mar 2025
Director
Bought
125,750
$295.51K
4.8%
TECH Bio-Techne
14 May 2024
Director
Sold at will
4,000
$335.38K
9.9%
OABI OmniAb, Inc.
23 May 2023
Director
Sold at will
9,000
$36.45K
0.4%
OABI OmniAb, Inc.
19 May 2023
Director
Sold at will
1,000
$4.05K
0.0%
OABI OmniAb, Inc.
18 May 2023
Director
Sold at will
50,000
$194.50K
2.0%
LGND LIGAND PHARMACEUTICALS INC
16 Dec 2022
Director
Sold, plan not stated
10,000
$618.66K
2.3%
LGND LIGAND PHARMACEUTICALS INC
17 Nov 2022
Chief Executive Officer
Sold, plan not stated
10,000
$783.17K
2.3%
LGND LIGAND PHARMACEUTICALS INC
16 Sep 2022
Chief Executive Officer
Sold, plan not stated
3,000
$268.05K
0.8%
LGND LIGAND PHARMACEUTICALS INC
15 Sep 2022
Chief Executive Officer
Sold, plan not stated
2,000
$180.00K
0.5%
TECH Bio-Techne
11 Aug 2022
Director
Sold, plan not stated
512
$197.32K
8.5%
TECH Bio-Techne
10 Aug 2022
Director
Sold, plan not stated
1,992
$751.19K
24.9%
TECH Bio-Techne
8 Jun 2022
Director
Sold, plan not stated
600
$219.65K
11.5%
TECH Bio-Techne
7 Jun 2022
Director
Sold, plan not stated
1,000
$364.31K
17.8%
LGND LIGAND PHARMACEUTICALS INC
12 Nov 2021
Chief Executive Officer
Sold, plan not stated
3,000
$481.50K
0.9%
LGND LIGAND PHARMACEUTICALS INC
5 Feb 2021
Chief Executive Officer
Sold, plan not stated
54,666
$11.12M
16.0%
LGND LIGAND PHARMACEUTICALS INC
27 Jan 2021
Chief Executive Officer
Sold, plan not stated
40,000
$7.28M
14.1%
LGND LIGAND PHARMACEUTICALS INC
25 Jan 2021
Chief Executive Officer
Sold, plan not stated
50,000
$7.95M
17.5%
TECH Bio-Techne
6 Nov 2020
Director
Sold, plan not stated
5,000
$1.50M
53.1%
TECH Bio-Techne
12 Feb 2020
Director
Sold, plan not stated
5,000
$1.03M
55.4%
LGND LIGAND PHARMACEUTICALS INC
31 Jul 2019
Chief Executive Officer
Bought
1,850
$176.58K
1.3%
TECH Bio-Techne
4 Jun 2019
Director
Sold, plan not stated
5,000
$1.02M
58.6%
LGND LIGAND PHARMACEUTICALS INC
31 May 2019
Chief Executive Officer
Bought
1,000
$108.20K
0.7%
LGND LIGAND PHARMACEUTICALS INC
14 May 2019
Chief Executive Officer
Bought
2,500
$283.75K
1.8%
LGND LIGAND PHARMACEUTICALS INC
13 Mar 2019
Chief Executive Officer
Bought
2,500
$285.73K
1.8%
LGND LIGAND PHARMACEUTICALS INC
30 Aug 2018
Chief Executive Officer
Sold, plan not stated
3,500
$903.88K
3.9%
TECH Bio-Techne
23 Aug 2018
Director
Sold, plan not stated
10,000
$1.88M
76.9%
LGND LIGAND PHARMACEUTICALS INC
17 Aug 2018
Chief Executive Officer
Sold, plan not stated
12,993
$3.16M
12.7%
LGND LIGAND PHARMACEUTICALS INC
16 Aug 2018
Chief Executive Officer
Sold, plan not stated
21,507
$5.19M
19.5%
LGND LIGAND PHARMACEUTICALS INC
15 May 2018
Chief Executive Officer
Sold, plan not stated
12,405
$2.23M
10.4%
LGND LIGAND PHARMACEUTICALS INC
15 Feb 2018
Chief Executive Officer
Sold, plan not stated
9,000
$1.41M
8.1%
LGND LIGAND PHARMACEUTICALS INC
24 Jan 2018
Chief Executive Officer
Sold, plan not stated
22,500
$3.71M
16.8%
LGND LIGAND PHARMACEUTICALS INC
19 Jan 2018
Chief Executive Officer
Sold, plan not stated
28,099
$4.32M
17.3%
LGND LIGAND PHARMACEUTICALS INC
17 Nov 2017
Chief Executive Officer
Sold, plan not stated
2,258
$316.89K
1.6%
LGND LIGAND PHARMACEUTICALS INC
16 Nov 2017
Chief Executive Officer
Sold, plan not stated
5,269
$750.99K
3.5%
LGND LIGAND PHARMACEUTICALS INC
5 Sep 2017
Chief Executive Officer
Sold, plan not stated
5,000
$650.00K
3.5%
LGND LIGAND PHARMACEUTICALS INC
8 Aug 2017
Chief Executive Officer
Sold, plan not stated
5,483
$685.38K
3.8%
LGND LIGAND PHARMACEUTICALS INC
21 Jun 2017
Chief Executive Officer
Sold, plan not stated
4,666
$559.92K
3.2%
LGND LIGAND PHARMACEUTICALS INC
9 Jun 2017
Chief Executive Officer
Sold, plan not stated
12,000
$1.38M
7.9%
LGND LIGAND PHARMACEUTICALS INC
20 Mar 2017
Chief Executive Officer
Sold, plan not stated
4,000
$436.40K
2.8%
LGND LIGAND PHARMACEUTICALS INC
8 Mar 2017
Chief Executive Officer
Sold, plan not stated
4,000
$428.24K
3.0%
LGND LIGAND PHARMACEUTICALS INC
22 Sep 2016
Chief Executive Officer
Sold, plan not stated
3,000
$352.02K
2.4%
TECH Bio-Techne
8 Sep 2016
Director
Sold, plan not stated
1,700
$186.72K
55.6%
LGND LIGAND PHARMACEUTICALS INC
7 Mar 2016
Chief Executive Officer
Sold, plan not stated
10,833
$1.11M
8.3%
LGND LIGAND PHARMACEUTICALS INC
6 Aug 2015
Chief Executive Officer
Sold, plan not stated
4,666
$516.95K
3.7%
LGND LIGAND PHARMACEUTICALS INC
9 Jun 2015
Chief Executive Officer
Sold, plan not stated
10,000
$928.81K
7.4%
LGND LIGAND PHARMACEUTICALS INC
15 Aug 2014
President & CEO
Bought
1,000
$54.97K
0.8%
LGND LIGAND PHARMACEUTICALS INC
12 Feb 2014
President & CEO
Sold, plan not stated
16,875
$1.27M
13.2%
LGND LIGAND PHARMACEUTICALS INC
16 Jan 2014
President & CEO
Sold, plan not stated
15,000
$960.00K
12.8%
LGND LIGAND PHARMACEUTICALS INC
18 Oct 2013
President & CEO
Sold, plan not stated
10,000
$550.00K
8.6%
LGND LIGAND PHARMACEUTICALS INC
16 Aug 2013
President & CEO
Sold, plan not stated
10,000
$428.50K
8.3%
LGND LIGAND PHARMACEUTICALS INC
5 Dec 2012
President & CEO
Bought
2,000
$36.06K
1.8%
LGND LIGAND PHARMACEUTICALS INC
13 Aug 2012
President & CEO
Bought
500
$8.20K
0.5%
LGND LIGAND PHARMACEUTICALS INC
4 May 2012
President & CEO
Bought
1,000
$12.04K
0.9%
LGND LIGAND PHARMACEUTICALS INC
17 Feb 2010
President & CEO
Bought
6,000
$10.02K
1.4%
LGND LIGAND PHARMACEUTICALS INC
13 Aug 2007
President & CEO
Bought
2,000
$11.72K
1.3%
LGND LIGAND PHARMACEUTICALS INC
15 Jun 2007
President & CEO
Bought
2,000
$13.40K
1.3%
60 decisions on file.